180 related articles for article (PubMed ID: 16674921)
1. RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells.
Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Okada Y; Doi T
Biochem Biophys Res Commun; 2006 Jun; 345(1):78-84. PubMed ID: 16674921
[TBL] [Abstract][Full Text] [Related]
2. Suppression of RUNX1 by siRNA in megakaryocytic UT-7/GM cells.
Okada Y; Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Doi T
Nucleic Acids Symp Ser (Oxf); 2006; (50):261-2. PubMed ID: 17150917
[TBL] [Abstract][Full Text] [Related]
3. Overexpression or knock-down of runt-related transcription factor 1 affects BCR-ABL-induced proliferation and migration in vitro and leukemogenesis in vivo in mice.
Yang LJ; Yu WD; DU JB; Chao S; Chen MX; Zhao HH; Guo JZ
Chin Med J (Engl); 2009 Feb; 122(3):331-7. PubMed ID: 19236814
[TBL] [Abstract][Full Text] [Related]
4. Increase of hematopoietic progenitor and suppression of endothelial gene expression by Runx1 expression during in vitro ES differentiation.
Sakai E; Kitajima K; Sato A; Nakano T
Exp Hematol; 2009 Mar; 37(3):334-45. PubMed ID: 19218012
[TBL] [Abstract][Full Text] [Related]
5. Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line.
Coppola S; Narciso L; Feccia T; Bonci D; Calabrò L; Morsilli O; Gabbianelli M; De Maria R; Testa U; Peschle C
Cell Death Differ; 2006 Jan; 13(1):61-74. PubMed ID: 15962006
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
7. Normal and transforming functions of RUNX1: a perspective.
Mikhail FM; Sinha KK; Saunthararajah Y; Nucifora G
J Cell Physiol; 2006 Jun; 207(3):582-93. PubMed ID: 16250015
[TBL] [Abstract][Full Text] [Related]
8. TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GM.
Takahashi W; Sasaki K; Kvomatsu N; Mitani K
Cancer Sci; 2005 Jun; 96(6):340-8. PubMed ID: 15958056
[TBL] [Abstract][Full Text] [Related]
9. Gatekeeper function of the RUNX1 transcription factor in acute leukemia.
Niebuhr B; Fischer M; Täger M; Cammenga J; Stocking C
Blood Cells Mol Dis; 2008; 40(2):211-8. PubMed ID: 17920312
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera.
Sasaki K; Yamagata T; Mitani K
Cancer Sci; 2008 Feb; 99(2):414-22. PubMed ID: 18271940
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha.
Peng ZG; Zhou MY; Huang Y; Qiu JH; Wang LS; Liao SH; Dong S; Chen GQ
Oncogene; 2008 Jan; 27(6):839-47. PubMed ID: 17684492
[TBL] [Abstract][Full Text] [Related]
12. RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice.
Nakamura Y; Ichikawa M; Oda H; Yamazaki I; Sasaki K; Mitani K
Leuk Res; 2018 Nov; 74():14-20. PubMed ID: 30278283
[TBL] [Abstract][Full Text] [Related]
13. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
Pozner A; Lotem J; Xiao C; Goldenberg D; Brenner O; Negreanu V; Levanon D; Groner Y
BMC Dev Biol; 2007 Jul; 7():84. PubMed ID: 17626615
[TBL] [Abstract][Full Text] [Related]
14. RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation.
Cammenga J; Niebuhr B; Horn S; Bergholz U; Putz G; Buchholz F; Löhler J; Stocking C
Cancer Res; 2007 Jan; 67(2):537-45. PubMed ID: 17234761
[TBL] [Abstract][Full Text] [Related]
15. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M
Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359
[TBL] [Abstract][Full Text] [Related]
16. The identification of (ETV6)/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6/RUNX1-positive lymphoid leukemic cells.
Starkova J; Madzo J; Cario G; Kalina T; Ford A; Zaliova M; Hrusak O; Trka J
Clin Cancer Res; 2007 Mar; 13(6):1726-35. PubMed ID: 17325341
[TBL] [Abstract][Full Text] [Related]
17. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
[TBL] [Abstract][Full Text] [Related]
18. RUNX1 and TGF-β signaling cross talk regulates Ca
Raghuwanshi S; Dahariya S; Sharma DS; Kovuru N; Sahu I; Gutti RK
FEBS J; 2020 Dec; 287(24):5411-5438. PubMed ID: 32281291
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1.
Feng J; Iwama A; Satake M; Kohu K
Br J Haematol; 2009 May; 145(3):412-23. PubMed ID: 19298589
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]